Clinical Trials Directory

Trials / Completed

CompletedNCT05305274

Age and Refraction in Predicting Myopia Progression in COVID-19

The Effect of Age and Refraction in Predicting Myopia Progression With Risk Under COVID-19 in a 3-year Follow-up of a Chinese Cohort

Status
Completed
Phase
Study type
Observational
Enrollment
34,400 (actual)
Sponsor
Tianjin Eye Hospital · Academic / Other
Sex
All
Age
6 Years – 15 Years
Healthy volunteers
Accepted

Summary

To determine the longitudinal changes of age and refraction in predicting myopia progression with risk under the coronavirus disease 2019 (COVID-19) pandemic in a 3-year follow-up of a Chinese cohort.

Detailed description

This was part of the large-scale Tianjin Eye Study, a population-based cohort study that longitudinally investigates the relationship between the age, refraction, and development of childhood RE in Tianjin, China.

Conditions

Interventions

TypeNameDescription
OTHERscreeningThis study included 34,400 students, as part of the Tianjin Eye Study who performed a 3-year follow-up from 2019 to 2021. All participants underwent yearly noncycloplegic refraction and ocular examinations. Time-related changes in sphere, cylinder, and spherical equivalent (SE) measurements in both sexes were analyzed.

Timeline

Start date
2019-10-01
Primary completion
2021-10-31
Completion
2021-12-01
First posted
2022-03-31
Last updated
2022-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05305274. Inclusion in this directory is not an endorsement.